Compare BCYC & AVBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BCYC | AVBH |
|---|---|---|
| Founded | 2009 | 2003 |
| Country | United Kingdom | United States |
| Employees | N/A | 151 |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 296.0M | 330.3M |
| IPO Year | 2019 | N/A |
| Metric | BCYC | AVBH |
|---|---|---|
| Price | $4.34 | $32.81 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 10 | 3 |
| Target Price | $13.90 | ★ $35.33 |
| AVG Volume (30 Days) | ★ 647.2K | 157.1K |
| Earning Date | 04-30-2026 | 04-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $350.70 |
| Revenue Next Year | N/A | $11.40 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.92 | $22.95 |
| 52 Week High | $9.18 | $34.18 |
| Indicator | BCYC | AVBH |
|---|---|---|
| Relative Strength Index (RSI) | 56.05 | 64.31 |
| Support Level | $4.25 | $31.52 |
| Resistance Level | $4.75 | $32.98 |
| Average True Range (ATR) | 0.17 | 0.82 |
| MACD | 0.05 | 0.03 |
| Stochastic Oscillator | 90.53 | 54.24 |
Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United Kingdom.
Avidbank Holdings Inc is a full-service commercial bank. It offers various services such as commercial and industrial lending, venture lending, structured finance, asset-based lending, sponsor finance, real estate construction, and commercial real estate lending.